DE2635932A1 - Guanidinderivate - Google Patents

Guanidinderivate

Info

Publication number
DE2635932A1
DE2635932A1 DE19762635932 DE2635932A DE2635932A1 DE 2635932 A1 DE2635932 A1 DE 2635932A1 DE 19762635932 DE19762635932 DE 19762635932 DE 2635932 A DE2635932 A DE 2635932A DE 2635932 A1 DE2635932 A1 DE 2635932A1
Authority
DE
Germany
Prior art keywords
bicyclo
radical
exo
formula
hept
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762635932
Other languages
German (de)
English (en)
Inventor
Douglas Lintin Swallow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE2635932A1 publication Critical patent/DE2635932A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
DE19762635932 1975-08-11 1976-08-10 Guanidinderivate Withdrawn DE2635932A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB33435/75A GB1492678A (en) 1975-08-11 1975-08-11 Guanidine derivatives

Publications (1)

Publication Number Publication Date
DE2635932A1 true DE2635932A1 (de) 1977-03-03

Family

ID=10352924

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762635932 Withdrawn DE2635932A1 (de) 1975-08-11 1976-08-10 Guanidinderivate

Country Status (17)

Country Link
JP (1) JPS5225743A (da)
AT (1) AT351045B (da)
AU (1) AU497534B2 (da)
BE (1) BE845052A (da)
CA (1) CA1087180A (da)
CH (1) CH625207A5 (da)
DE (1) DE2635932A1 (da)
DK (1) DK362576A (da)
FI (1) FI762158A (da)
FR (1) FR2320736A1 (da)
GB (1) GB1492678A (da)
IE (1) IE43488B1 (da)
NL (1) NL7608903A (da)
NO (1) NO143993C (da)
PL (1) PL98956B1 (da)
SE (1) SE7608929L (da)
ZA (1) ZA764126B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
US4628061A (en) * 1981-12-23 1986-12-09 National Research Development Corporation Prostaglandins
JPS59501110A (ja) * 1982-06-21 1984-06-28 インステイテユ−ト オルガニチエスコゴ シンテザアカデミイ ナウク ラトビスコイ エスエスア−ル 抗腫瘍活性を有する薬剤組成物
US20060100225A1 (en) * 2004-03-23 2006-05-11 Xi Chen Heteroaryl guanidines; inhibitors of viral replication

Also Published As

Publication number Publication date
ZA764126B (en) 1977-06-29
NO143993C (no) 1981-05-27
NL7608903A (nl) 1977-02-15
GB1492678A (en) 1977-11-23
CA1087180A (en) 1980-10-07
BE845052A (fr) 1977-02-10
AU1595676A (en) 1978-01-19
AU497534B2 (en) 1978-12-14
FR2320736B1 (da) 1980-11-07
CH625207A5 (en) 1981-09-15
AT351045B (de) 1979-07-10
NO762774L (da) 1977-02-14
SE7608929L (sv) 1977-02-12
IE43488B1 (en) 1981-03-11
IE43488L (en) 1977-02-11
FR2320736A1 (fr) 1977-03-11
ATA592976A (de) 1978-12-15
NO143993B (no) 1981-02-16
JPS5225743A (en) 1977-02-25
FI762158A (da) 1977-02-12
PL98956B1 (pl) 1978-06-30
DK362576A (da) 1977-02-12

Similar Documents

Publication Publication Date Title
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
US4051256A (en) Guanidine derivatives
CH629761A5 (de) Verfahren zur herstellung neuer oximaetherverbindungen.
DE9290063U1 (de) Chinuclidin-Derivate
DE2846251C2 (da)
DE2164058C3 (de) Basisch substituierte Benzylphthalazinon-Derivate, ihre Salze, Verfahren zu ihrer Herstellung und diese Produkte enthaltende pharmazeutische Präparate
DD207718A5 (de) Verfahren zur herstellung von 2-guanidino-4-heteroarylthiazolen
DE60005517T2 (de) Kaliumkanal-blockierende mittel
DE2635932A1 (de) Guanidinderivate
EP1335720A1 (de) Sulfonamiden zur behandlung von erkrankungen des zentralen nervensystems
EP0147707B1 (de) 1,7-Diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur Verwendung bei der Bekämpfung von Krankheiten
DE3043437C2 (da)
AT352749B (de) Verfahren zur herstellung von neuen guanidin- derivaten und von deren saeureadditionssalzen
DD145266A5 (de) Verfahren zur herstellung von 6-methoxy-2-acetylnaphthalinoxim-derivaten
DE2243789A1 (de) 1-aminoisochinolinderivate, ihre salze mit saeuren und quartaeren ammoniumsalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3043446C2 (da)
DE3043498C2 (da)
DE3220185A1 (de) 4-amino-benzylamin-derivate, verfahren zu ihrer herstellung, sowie ihre verwendung als pharmazeutica
DE2610679C2 (de) Sulfinylgruppenhaltige Oximätherderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
EP0269985A2 (de) Neue 1-Aryloxy-3-amino-2-propanole, ihre Herstellung und Verwendung
DE3218743A1 (de) Isoprenylaminderivate und saeureadditionssalze davon
DE2002107A1 (de) Neue organische Verbindungen und Verfahren zu deren Herstellung
DE2062055B2 (de) Propanolamin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3907512C2 (de) Neue Aryloxy-alkylamine, deren Herstellung und diese enthaltende Arzneimittel
EP0329010B1 (de) Noremopamil, seine Herstellung und Verwendung

Legal Events

Date Code Title Description
8141 Disposal/no request for examination